About 688 results

ALLMedicine™ Pure Red Cell Aplasia Center

Research & Reviews  179 results

Associations between Autoimmune Conditions and Gastric Cancer Risk among Elderly Adults...
The American Journal of Gastroenterology; Song M, Camargo MC et. al.

Jan 15th, 2022 - Pernicious anemia (PA) is a risk factor for gastric cancer. Other autoimmune conditions may also contribute. In a case-control study, we evaluated 47 autoimmune conditions among 35,499 gastric cancers and 200,000 cancer-free controls. Six conditio...

Post-Hematopoietic Stem Cell Transplantation Immune-Mediated Anemia: A Literature Revie...
Blood Advances; Migdady Y, Pang Y et. al.

Jan 1st, 2022 - Anemia following allogeneic hematopoietic stem cell transplantation (HCT) can be immune- or non-immune mediated. Auto- or alloimmunity due to blood groups incompatibility remain an important cause if post-HCT immune-mediated anemia. ABO incompatib...

CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disor...
Medicine Xu Q, Yu J et. al.

Dec 30th, 2021 - Monoclonal gammopathy of undetermined significance (MGUS) is a clinically asymptomatic clonal plasma cell or lymphoplasmacytic proliferative disorder. Recently, some case reports have described the association of pure red cell aplasia (PRCA) with ...

Pure red cell aplasia secondary to rheumatoid arthritis: a case report.
Journal of Medical Case Reports; Weerasinghe S, Karunathilake P et. al.

Dec 8th, 2021 - Rheumatoid arthritis is a common autoimmune disease with many extra-articular manifestations. Pure red cell aplasia is a rare manifestation of rheumatoid arthritis and is sparsely documented in the literature, with a variable clinical outcome foll...

True thymic hyperplasia causing pure red cell aplasia: a case report.
Interactive Cardiovascular and Thoracic Surgery; Mohammad A, Dawson AG et. al.

Nov 19th, 2021 - Pure red cell aplasia caused by true thymic hyperplasia is extremely rare. We report the case of a 25-year-old female diagnosed with pure red cell aplasia. Following a thymectomy confirming true thymic hyperplasia and corticosteroid therapy, compl...

see more →

Drugs  90 results see all →

Clinicaltrials.gov  3 results

Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

Sep 16th, 2020 - This is an open-label, single-arm study to evaluate the safety and efficacy of bortezomib plus dexamethasone for acquired pure red cell aplasia failure or relapse after first-line treatment.

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Sep 21st, 2016 - This project will validate our new high-transition-temperature (high-Tc; operating at 77°K, cooled by liquid nitrogen) superconducting magnetic susceptometer as the most clinically effective means for monitoring iron overload in patients who requi...

Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment

Jan 29th, 2014 - Recombinant human erythropoietin was the first biotherapeutic medicinal product derived from recombinant DNA technology for the treatment of anemia in patients with chronic kidney disease (CKD). Although r-HuEpo raises hemoglobin levels in CKD and...

see more →

News  3 results

Brentuximab Vedotin in a Patient With Aggressive Systemic Mastocytosis and Pure Red Cell Aplasia
Cooper K, Richter J et. al.

Sep 21st, 2015 - Backround: Mastocytosis is a rare disease with a variable clinical course. Pure red cell aplasia has not been frequently reported in association with aggressive systemic mastocytosis.

FDA Safety Changes: Actonel, Gardasil, Myfortic

Sep 2nd, 2009 - This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. September 2, 2009 — The US Food and Drug Administration (...

FDA Safety Changes: Strattera, Aptivus, CellCept

Aug 5th, 2009 - This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. August 5, 2009 — The US Food and Drug Administration (FDA...

see more →